Market Overview The urinary incontinence therapeutics market encompasses a comprehensive portfolio of pharmaceutical formulations, injectable neuromodulators, and medical treatments designed to manage and treat conditions such as overactive bladder (OAB), urge urinary incontinence (UUI), and stress urinary incontinence (SUI). Valued at approximately USD 4.6 billion to USD 4.9 billion, the...